Discover Clarivate

search

Support Investors Careers Login

Clarivate Corporate
Clarivate for Academia & Government
Clarivate for Life Sciences & Healthcare
Clarivate for Intellectual Property

Life Sciences & Healthcare

Main Menu

Products and services
Life Sciences & Healthcare

Deliver safe, effective and commercially successful treatments to patients faster.

Confidently make smart, patient-centric decisions and navigate roadblocks with the help of AI-powered intelligence platforms that are fueled by extensive and specialized therapeutic area data and contextualized insights.

Explore
north_east

Featured

Integrating patient centricity into the Menarini mature brand strategy for commercial excellence

Integrating patient centricity into the Menarini mature brand strategy for commercial excellence

Medtech Trends to Watch in 2024

Medtech Trends to Watch in 2024

Companies to Watch: Antibody Drug Conjugates

Companies to Watch: Antibody Drug Conjugates
Real-World Data Products and services

Whether you have data analysis capabilities, need dynamic dashboards or custom data insights and services, we are here to help you succeed.

Areas of expertise

Real-World Data Products

Real-World Data Consulting & Insights

Peer-reviewed publications

Peer-reviewed publications featuring Clarivate Real-World Data

Portfolio Strategy and Business Development Products and services

Transformative intelligence that connects data and expertise, providing the insight to prioritize treatments.

Market assessment

Disease Landscape and Forecast

Epidemiology Intelligence

Cortellis Competitive Intelligence

Real-World Data

Biosimilars

Competitive intelligence

Cortellis Competitive Intelligence

Disease Landscape and Forecast

Cortellis Product Intelligence

Partner identification and deal-making

Cortellis Deals Intelligence

Cortellis Competitive Intelligence

BioWorld

Research and Development Products and services

Equip your complete R&D ecosystem with the intelligence needed to make decisions with confidence and speed.

Discovery and development

Cortellis Drug Discovery Intelligence

Cortellis Clinical Trials Intelligence

OFF-X Translational Safety Intelligence

Benchmarking and R&D Consulting Services

BioWorld

Regulatory and compliance

Cortellis Regulatory Intelligence

Cortellis CMC Intelligence

Pharmacovigilance and drug safety

OFF-X Translational Safety Intelligence

Drug Safety Triager

Dialog

Commercialization Products and services

Commercial expertise to help ensure your therapies reach the patients who need them.

Products and services

Market Access and Commercialization

Commercial and pharma product launch strategy

Real-World Data

Consulting services

Manufacturing and Supply Chain Products and services

Our industry experts and data scientists help make sense of the vast amount of market performance, API, patent, and regulatory data so you can continue to broaden patient access to medicines and keep the engines of innovation going.

Products and services

Cortellis Product Intelligence

Optiqs360 Digital

Consulting Services Products and services

Our highly experienced team of expert consultants utilize integrated research, data, and analytics to enable clients to make better, more informed decisions in a rapidly changing landscape.

Areas of expertise

Consulting Overview

Meet our trusted partner

Thought leadership and resources

Commercial Consulting Services

Research and Development

Technology Consulting

Integrated Patient Journey

Benchmarking and R&D Consulting Services

Medtech Products and services

Connected data, advanced analytics and streamlined workflows to accelerate your time to market and patients.

Products and services

Portfolio Strategy and Planning

Market Access

Regulatory Affairs

Commercial Launch

Insights & Reports

BioWorld

APIs and Data Products Products and services
About
About

A leading provider of global transformative intelligence.

Clarivate™ is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property and Life Sciences & Healthcare.

Explore
north_east

Featured articles

Clarivate Appoints Former ProQuest CEO Matti Shem Tov as the Company’s Next CEO

Clarivate Appoints Former ProQuest CEO Matti Shem Tov as the Company’s Next CEO

How Clarivate uses Artificial Intelligence you can trust to transform your world

How Clarivate uses Artificial Intelligence you can trust to transform your world
News About

Clarivate newsroom

News

Support About

Whether you’re looking for product support, learning and training or have billing or invoice inquiries, we can help.

Support areas

Account services

Learning and training

Product support

Sustainability
About

We have embraced an extensive, holistic approach to sustainability in order to drive measurable impact.

Sustainability at Clarivate

Voice of Customer About

See how we keep our customers first

Voice of Customer

Customer Stories About

See the stories

Customer Stories
Insights
Insights

Explore Clarivate insights

Stay informed with the latest insights, news, and research from Clarivate. Explore our blogs, webinars, podcasts, reports, and case studies to stay ahead of trends and innovations in your field.

Explore
north_east

Featured

Emerging Deal Making Trends in Biotech and Pharma

Explore 2024 deal-making trends for pharma and biotech.

Medical Technologies to Watch 2024

Emerging medical technologies poised to transform patient care.
Blog Insights

Our blogs

Life Sciences and Healthcare blog

Thought Leadership Insights

Life Sciences and Healthcare

The innovation-complexity paradox in life sciences

Geographic expansion and supply chain risk mitigation

How pharmas and medtechs can navigate regulatory disruption in Washington, D.C.

Webinars Insights

Our webinars

Turning Complexity into Custom Epidemiology

How pharmas and medtechs can navigate regulatory disruption in Washington, D.C.

Medtech Trends to Watch 2025: Geographic expansion and supply chain risk mitigation
Contact us

Product logins

Find logins to all Clarivate products below.

home • Research Reports

Disease Landscape and Forecast Insights

Comprehensive market intelligence and actionable insights help you optimize your long-term disease strategy

1
2
3
4
5
6
...
8

Report June 27, 2023

Non-Hodgkin’s Lymphoma and Chronic Lymphocytic Leukemia – Unmet Need – Detailed, Expanded Analysis: Relapsed or Refractory DLBCL (US/EU)

Relapsed / refractory diffuse large B-cell lymphoma (R/R DLBCL) is an aggressive disease with significant unmet need. The treatment landscape has evolved since the approval of various novel…

north_east

Report May 23, 2023

Myelodysplastic Syndromes – Epidemiology – Epidemiology Dashboard

Clarivate Epidemiology’s coverage of myelodysplastic syndromes (MDS) comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report both the diagnosed…

north_east

Report May 23, 2023

Myelodysplastic Syndromes – Epidemiology – Mature Markets

Clarivate Epidemiology’s coverage of myelodysplastic syndromes (MDS) comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report both the incidence and…

north_east

Report May 23, 2023

Myelodysplastic Syndromes – Epidemiology – Extrapolated Worldwide Coverage

Clarivate’s Extrapolated Worldwide Coverage is the first and only evidence-based data set of epidemiological forecasts for key MDS patient populations, covering 171 countries and more than 99% of…

north_east

Report April 27, 2023

Myelodysplastic Syndromes – Unmet need – Unmet Need – Myelodysplastic Syndromes (US/EU)

Myelodysplastic syndromes (MDS) are a heterogeneous collection of hematopoietic stem-cell disorders that disrupt normal hematopoiesis in the bone marrow. All pharmacological approaches to treating…

north_east

Report March 28, 2023

Acute Myeloid Leukemia – Unmet Need – Unmet Need – First-Line Intensive-Induction-Eligible Acute Myeloid Leukemia (US/EU)

Acute myeloid leukemia (AML) is the most common acute leukemia in adults, originating from mutant myeloid precursor cells. Presently, the AML drug market is dominated by chemotherapy backbones, but…

north_east

Report March 24, 2023

Acute Lymphoblastic Leukemia – Epidemiology – Asia-Pacific

Clarivate Epidemiology’s coverage of acute lymphoblastic leukemia (ALL) comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report both the incidence and…

north_east

Report March 23, 2023

Acute Lymphoblastic Leukemia – Epidemiology – Middle East & Africa

Clarivate Epidemiology’s coverage of acute lymphoblastic leukemia (ALL) comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report both the incidence and…

north_east

Report March 23, 2023

Acute Lymphoblastic Leukemia – Epidemiology – Europe

Clarivate Epidemiology’s coverage of acute lymphoblastic leukemia (ALL) comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report both the incidence and…

north_east

Report March 23, 2023

Acute Lymphoblastic Leukemia – Epidemiology – Americas

Clarivate Epidemiology’s coverage of acute lymphoblastic leukemia (ALL) comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report both the incidence and…

north_east

Report March 23, 2023

Acute Lymphoblastic Leukemia – Epidemiology – Emerging Markets

Clarivate Epidemiology’s coverage of acute lymphoblastic leukemia (ALL) comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report both the incidence and…

north_east

Report March 23, 2023

Acute Lymphoblastic Leukemia – Epidemiology – Extrapolated Worldwide Coverage

Clarivate’s extended worldwide coverage is the first and only evidence-based data set of epidemiological forecasts for key acute lymphoblastic leukemia populations covering 171 countries and more…

north_east

1
2
3
4
5
6
...
8

Follow us

Contact us

Sales enquiries north_east

Customer service north_east

Support north_east

Academia & Government
Life Sciences & Healthcare
Intellectual Property
Company

language Regional sites
简体中文 (Chinese) 日本語 (Japanese) 한국어 (Korean) 繁体中文 (Traditional Chinese) América Latina (ES)

© 2026 Clarivate. All rights reserved.

Legal
Trust Center
Standards
Privacy center
Privacy notice
Cookie notice
Career Fraud Warning
Transparency in Coverage
Modern slavery statement
Cookie preferences

Search Clarivate

Fraud Warning

Please be advised that recently there have been fraudulent job offers and interviews using the Clarivate name, logo and even names of our colleagues.

Please be aware that Clarivate will:

Never ask for payment of any kind as part of our hiring or onboarding processes
Never ask an applicant to email sensitive personal information, such as a Social Security Number, birthdate, credit card or bank account information
Never issue pre-employment checks to purchase office supplies
Never ask you to pay up for an external course and upskill

If you have any question about a position posted in our company name, please check our current open positions on the Clarivate website Careers pages or contact one of our recruiting team members directly.

If you have been the victim of a scam, please contact your local law enforcement agency.

Federal Transparency In Coverage Rule

This link leads to the machine-readable files that are made available in response to the federal Transparency in Coverage Rule and includes negotiated service rates and out-of-network allowed amounts between health plans and healthcare providers. The machine-readable files are formatted to allow researchers, regulators, and application developers to more easily access and analyze data.

View now north_east